IP Library › Patent Application 12824136
Patent Application
App. No. 12/824,136

METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/824,136
Abstract

A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at about 12 hours and the use of the composition to treat various neurological diseases, including multiple sclerosis. A method of selecting individuals based on responsiveness to a treatment, including, for example, identifying individuals who responded to treatment with a sustained release fampridine composition.

Claims (2)

1 . A method of establishing steady state plasma pharmacokinetics of 4-aminopyridine, said method comprising administering sustained release 4-aminopyridine, as set forth herein.

2 . The method of claim 1 further comprising a step of maintaining the steady state plasma pharmacokinetics of 4-aminopyridine.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2010
From: BLIGHT, ANDREW R.; COHEN, RON
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 025222/0615 →